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Abstract. Fluorescence imaging in diffusive media is an emerging im-
aging modality for medical applications that uses injected fluorescent
markers that bind to specific targets, e.g., carcinoma. The region of
interest is illuminated with near-IR light and the emitted back fluores-
cence is analyzed to localize the fluorescence sources. To investigate
a thick medium, as the fluorescence signal decreases with the light
travel distance, any disturbing signal, such as biological tissues intrin-
sic fluorescence called autofluorescence is a limiting factor. Several
specific markers may also be simultaneously injected to bind to dif-
ferent molecules, and one may want to isolate each specific fluores-
cent signal from the others. To remove the unwanted fluorescence
contributions or separate different specific markers, a spectroscopic
approach is explored. The nonnegative matrix factorization NMF is
the blind positive source separation method we chose. We run an
original regularized NMF algorithm we developed on experimental
data, and successfully obtain separated in vivo fluorescence
spectra. © 2010 Society of Photo-Optical Instrumentation Engineers.
DOI: 10.1117/1.3491796
Keywords: fluorescence optical imaging; spectroscopy; source separation;
autofluorescence.
Paper 10039R received Jan. 27, 2010; revised manuscript received Jul. 21, 2010;
accepted for publication Aug. 16, 2010; published online Sep. 30, 2010.Introduction
edical diagnostic systems based on fluorescent imaging are
nvisioned to be noninvasive, easy to use, and cost effective.
luorescent markers are injected into a patient, and bind spe-
ifically to targeted compounds, such as tumors.1 Several spe-
ific markers can be injected at once, and bind to different
ompounds or organs; that method is used to survey different
iological processes or organs, such the evolution of carci-
oma, or, for example, to measure blood flow. The region of
nterest is illuminated with near-infrared NIR light; an opti-
al wavelength range can be defined between 600 and
00 nm, where tissue absorption is lower. The excitation
avelength is thus selected to ease the tissue penetration, and
o optimally excite the injected markers. Finally, the emitted
ack fluorescence signal is measured and the fluorescent
ource is localized. So far, NIR fluorescence imaging is
ainly used on small animals where some markers are avail-
ble for injection, and where the layer of biological tissues to
xplore does not exceed a few centimeters. In such a case, a
iological tissues intrinsic fluorescence, called
utofluorescence,2 exists, but is insignificant compared to the
uorescent marker signal. To investigate thick media for
edical diagnostic applications 4 cm, the autofluores-
ence must be considered. As the fluorescence signal becomes
xponentially weak with the distance light travels, an auto-
ddress all correspondence to Anne-Sophie Montcuquet, Tel: +33 438 782 758;
-mail: anne-sophie.montcuquet@cea.frournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1fluorescence signal remains constant and becomes a limiting
factor. The analysis of a fluorescence signal impaired by au-
tofluorescence may lead to a wrong localization of the mark-
ers; the signal must be preprocessed to remove autofluores-
cence.
Many algorithms to unmix fluorescence spectra and to fil-
ter autofluorescence have already been developed and tested
on small animal examination equipments: methods such as
nonlinear least squares,3 spectra subtraction,4 principal com-
ponent analysis PCA, independent component analysis,
ICA and singular value decomposition SVD were
proposed.5–8 In particular, the ICA method requires sources to
be statistically independent, which is not appropriate hypoth-
esis for our fluorescence unmixing problem, and SVD consid-
ers orthogonal sources and allows negative values. Much a
priori knowledge about the nature of the sources, such as
sparsity or independence, is taken into account in these meth-
ods. But a principal that must be considered is nonnegativity.
Many real-world data are nonnegative, as fluorescence data
are, and the resulting unmixed fluorescence spectra have a
physical meaning only when nonnegative.
In 1987, Henry9 raised the issue of the nonexistent nonne-
gativity constraint in the factor analysis algorithms SVD,
PCA, etc.. In light of this observation, many original algo-
rithms were developed. One of them was the positive matrix
factorization PMF, developed by Paatero and Tapper10 in
1083-3668/2010/155/056009/14/$25.00 © 2010 SPIESeptember/October 2010  Vol. 1551
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J994, which uses alternative least squares ALS to minimize
chosen cost function. Expectation maximization11 EM also
inimizes a cost function by the use of an auxiliary function.
inally, from those methods the nonnegative matrix factoriza-
ion NMF was forged, notably investigated by Paaetero and
apper, which gained popularity in 2001 through the works of
ee and Seung.12
NMF is a useful matrix decomposition for multivariate
ata, that differs from the methods already cited SVD, PCA
n that it forces the matrix factors to be nonnegative. Thanks
o this distinctive feature, NMF plays a major role in a wide
ange of applications, such as in chemometrics commonly
nown as self–modeling curve resolution13, bioinformatics,14
euroscience,15 text mining,16 or spectral analysis.17 In 2006,
obinet et al.18 used the NMF decomposition on spectro-
copic data to unmix several pure fluorescence spectra, and
ater, as a preprocessing step for Raman spectra analysis of
iomedical samples.19 Since 2008, Xu et al.17 used and Xu
nd Rice20 have a multivariate curve resolution MCR
ethod to separate different fluorescence spectra, including
he autofluorescence, based on multispectral imaging data.
he MCR model is also based on matrix factorization, and
onstrained to nonnegativity; Xu et al. couple this method to
he ALS optimization approach. Their method is probably the
losest to our work, but sill differs from experimental setup
sed selection of few emission wavelengths, and often sev-
ral excitation wavelengths while, we use unique excitation
avelength and use the total emission spectrum from
00 to 1000 nm, thanks to an imaging spectrometer to opti-
ization method suggested ALS versus multiplicative update
ules. As blind source separation problems are often depicted
x
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Fig. 1 Sum of a a specific fluorescence signal and bournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1and solved under a matrix factorization form, the result
strongly depends on the a priori knowledge we introduce.
Work on matrix factorization and spectroscopy run by Gobi-
net et al.18 inspired our work, but fluorescence spectroscopy
introduces fluorescent markers and thus a priori knowledge
that was not taken into account in Gobinet’s work. Xu et al.17
work on in vivo small-animal imaging is close to our problem,
but still different from deep imaging problem where autofluo-
rescence may have same intensity level than specific fluores-
cence signal. Finally, as already underlined, both teams use
different resolution methods.
For in vivo fluorescence spectroscopy, the unmixing prob-
lem is referred to as a blind source separation problem since
fluorescence spectra may vary according to the fluorescent
dye biological environment. Fluorescence spectra to separate
are also supposed statistically dependent, which filters out
many methods such as ICA. Finally, the NMF algorithm
seems to be, in many ways, more suitable in blind positive
spectra separation than other separation methods. We propose
to test this method on spectroscopic data and to define a new
regularized NMF algorithm that may better suit fluorescence
spectroscopy data in particular cases.
First, we introduce the spectra unmixing problem: from a
mixed fluorescence signal composed of a known number of
sources, we want to obtain separated contributions for each
fluorescence source; the NMF decomposition is proposed to
unmix fluorescence spectra, and the method is explained. Sev-
eral NMF algorithms exist, based on diverse criteria to mini-
mize and optimization methods: we present in the second part
a classical NMF algorithm that deals with multiplicative up-
date rules.12 As with all blind source separation methods, it is
S2
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Jmpossible to find a unique NMF decomposition. In a second
art we study the nonuniqueness issue and suggest regulariza-
ions and a priori knowledge considerations to refine the so-
ution set. Two axes are examined: the influence of initializa-
ion of matrices and regularization on initialization. Both
ssues are studied on a breast simulation case; a regularized
MF algorithm that selects appropriate initialization or takes
nto account some a priori knowledge on the fluorescence
pectra we want to unmix is presented; associate original up-
ate rules are also detailed. Finally, we ran our NMF algo-
ithm on experimental in vivo data with success. Two fluores-
ent markers—ICG loaded into nanoparticules ICG-LNP
nd Alexa 750—were placed on mice to simulate marked tar-
ets. Adding the autofluorescence signal, the NMF algorithm
chieved the separation of three overlapping fluorescent
ources. A second example deals with detection of a multi-
epth target: the same marker ICG-LNP at different depths
s placed on a mouse, and deeper markers are mixed up with
utofluorescence signal. The results of both experiments are
resented in the last section.
NMF
.1 NMF and Spectroscopy
et us consider a fluorescence spectrum m measured in a
edium that for example contains two kinds of fluorescenceournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1sources: fluorescence spectra s1 and s2 may overlap, but have
distinct emission peaks. Thus, the measured fluorescence m is
a mixture of both sources of the medium; if we call a1 and a2
the amount of respectively spectra s1 and s2 in m, all those
quantities being nonnegative, we can write
m = a1s1 + a2s2= a1 a2 s1,1 . . . s1,N
s2,1 . . . s2,N
 = aS
1 N 1 2 2 N
.
1
It can be easily generalized to a mixing model with P
distinct sources present in the medium. The fluorescence spec-
trum m is now a linear combination of the P sources spectra
si , i 1, P, in quantities ai , i 1, P. Vector a
= a1 , . . . ,aP is considered as the weight vector, and S as the
spectra matrix, both containing as much elements P as fluo-
rescent sources to separate. The following equation depicts
the decomposition obtained for P sources:2
We now finally enlarge the example to a set M of Ns spectra acquired on a N wavelength range, for P sources present in the
edium. We have thus:
3This reasoning led to a matrix factorization, that only deals
ith nonnegative components, which brings us close to the
MF definition. NMF proposes to find a couple of matrices
A ,S with nonnegatives coefficients, whose product ap-
roaches the best possible the initial non-negative data M.
ndeed, the classical NMF definition says12
Given a nonnegative matrix MRNsN, find nonnegative
atrix ARNsP and SRPN such thatM  AS , 4
where nonnegative matrices are matrices whose all factors are
nonnegative.
To find the particular matrices A and S that satisfy Eq. 4,
two distinct steps must be considered. First, a distance be-
tween M and model AS is defined. Then, in a second step,
optimizing this distance under the nonnegativity constraintSeptember/October 2010  Vol. 1553
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Jould lead to the a factorization solution. Several “distances”
the Eunclidean distance, the Kullback-Leibler
ivergence,10,12 etc. and different optimization methods
ALS, update rules may be chosen to obtain the NMF de-
omposition.
.2 NMF Algorithm
any NMF algorithms have been proposed since Paatero and
apper,10 but in 2001, NMF popularity increased after Lee
nd Seung published two original NMF algorithms,12 based
n the use of multiplicative update rules to minimize square
f the euclidean distance and the Kullback-Leibler divergance
etween and M and AS.
.2.1 Cost function definition
ere, we chose our cost function F as the square of the Eu-
lidean distance between M and AS Refs. 12 and 21, and
efined as
F = 
n=1
Ns

=1
N ms − 
p=1
P
aspsp2 = M − AS2. 5
he cost function F is lower bounded by 0.
.2.2 Optimization
he following optimization problem is thus considered:
roblem 1. Find couple A ,S such as A ,S
argminA,S0M−AS22.
Many methods can be implemented to solve this problem.
he gradient descent is probably the simplest, and most fa-
ous one, but it is also known for a slow convergence. Other
aster methods, such as the conjugate gradient, are usually
ore complicated to implement.22 ALS is also commonly
sed in such problems. In 2001, Lee and Seung12 proposed
ultiplicative update rules to minimize F: it offers a good
ompromise between speed and ease of implementation to
olve Problem.
heorem 1. The distance M−AS2 is nonincreasing under
he update rules:
Sp← Sp
AtMp
AtASp
Anp← Anp
MStnp
ASStnp
, 6
here Xt is the transpose of a matrix X. The proof of this
heorem is given in Lee and Seung’s publication.12
We became interested in these update rules precisely be-
ause of their ease of implementation and speed, for which
hey were initially created. Finally, they are easily convertible
f some regularization is required. We thus defined original
egularized update rules adapted to our fluorescence data
hich take into account a priori knowledge on the fluores-
ence spectra.
.3 Nonuniqueness of the NMF Decomposition
he chosen cost function F is not jointly convex in matrices
and S: there are numerous local minima to the function and
onuniqueness of the NMF factorization. Let us assume aournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1factorization of M by the product of some matrices A and S
exists. If we now consider any invertible matrix T of size
PP, then a new couple A ,S of solutions is easily found:
7
Without any constraint and a priori information brought to
the optimization step, there is an infinity of factorizations of
matrix M. The solution range may nevertheless be imposing
regularization to the algorithm, as for example non-negativity
imposed to A and S coefficients.23
Techniques to moderate ambiguity of factorization are re-
quired. Adding constraints to original cost function F and
incorporating a priori information restrains the solutions set,
and may be sufficient to solve the NMF problem uniquely.24
In next section, we propose to study breast simulations of
fluorescence detection and autofluorescence removal by NMF,
before to test our algorithm on in vivo data in last part of this
paper. Studies will focus on initialization problem and use of
the a priori on fluorescence sources.
3 Simulation Studies
We chose to run simulations based on breast data: many clini-
cal experiments on this organ enabled us to design a computer
breast model with realistic optical properties of tissues. A fake
marked tumor is introduced to the model, and consistent mod-
eling fluorescence acquisitions of the simulated breast are ob-
tained, with modified depth of the marked tumor.
3.1 Definition of Simulated Matrices A and S
The breast fluorescence acquisition model is composed of an
homogeneous autofluorescence distribution and of a specific
fluorescence contribution to mimic the tumor pointed out by
an injected fluorescent marker. Signal ratio between healthy
tissue and tagged tumor depends on biomarkers. From bibli-
ography, and from experience, ratios from 3 to 15 Ref. 25
for more specific-to-tumor markers are usual, while new
generation of activatable fluorescent markers reach ratios
from 24 to 180 Refs. 26–29, depending on wavelength
range, and conditions of experimentation ex vivo or in vivo,
and site of tumor. We chose for our simulation study a ratio
between tumor and healthy tissue approximately equal to 10
when tumor is 1 mm deep in tissues.
The specific fluorescence part is the product of a weight
vector A1 by a fluorescence spectrum S1 	see Fig. 1a
.
A priori, the autofluorescence part is the product of the weight
vector A2 by a fluorescence spectrum S2 	see Fig. 1b
.
Simulated spectra are Gaussian models chosen close to usu-
ally used and observed fluorescence spectra of autofluores-
cence and fluorescent markers indocyanine green, for ex-
ample. Finally the total simulated acquisition is obtained by
adding the specific fluorescence and the autofluorescence
parts 	Fig. 1c
.
3.2 Contrast
We introduce straight away the contrast cT,N, measured be-
tween tumorous area T and normal tissues area N: it charac-
terizes the improvement of tumor detection after autofluores-September/October 2010  Vol. 1554
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Jence removal, on simulation and experimental results.
verage intensity of fluorescence signal is measured on both
oncerned regions of interest ROIs; T¯ and N¯ are, respec-
ively, the average intensities in photons per pixel of areas T
nd N defined in Fig. 1:
cT,N =
T¯ − N¯
T¯ + N¯
. 8
he closer to one the contrast value gets, the better will be the
etection.
.3 Optical Parameters
linical studies allowed us to have measurement of breast
issues optical parameters at our disposal. In 2001, Cerussi et
l. conducted clinical measurements and obtained average re-
uced scattering and absorption coefficients of breast, depend-
ng on wavelength.30 From those results, we defined average
imulation values of absorption coefficient a in inverse cen-
imeters and reduced scattering coefficient s in inverse
entimeters on wavelength range 700 to 1000 nm see Fig.
.
.4 Light Propagation
ropagation of light in turbid media has been extensively dis-
ussed. To simulate decrease of intensity emitted by fluores-
ent markers embedded in diffusive tissues, and to estimate
volution of contrast between specific fluorescence and autof-
uorescence depending on depth of fluorescent markers in tis-
ues, classical diffusion approximation is considered. Thus,
or homogeneous medium and continuous illumination, the
hoton density  in W m−2 satisfies the following derivative
quation:
r − k2r = −
Sr
D
9
here r is the marker position in medium, the diffusion term
is defined as D=1 / 3a+s, k is defined as k
3as1/2, and Sr is the isotropic source term. Solution 
f this equation, assuming an infinite medium, is known. Even
f the infinite medium hypothesis does not correspond to our
ase, it has the benefit of having an analytic solution and it
wavelength (nm)
Absorption µa
c
m
-1
700 750 800 850 900 950 10
0.05
0.1
0.15
0.2
0.25
(a)
Fig. 2 Average values chosen for breast tissuesournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1enables us to easily describe the light propagation model and
changes on spectra. Such a hypothesis would be annoying for
a more precise study, especially concerning side effects. For
now, however, this approximation is sufficient, and the solu-
tion  to the diffusion equation is used:
 =
exp	− kr

4Dr
. 10
Wavelength-dependent absorption and reduced scattering
coefficients of breast tissue are responsible for modification of
markers emission spectrum. After fluorescent markers are ex-
cited, the emitted photons propagate back in tissues following
Eq. 9 to finally reach detectors, as depicted in Fig. 3. Thus,
the emission spectrum of detected fluorescent markers Sd
varies from ex vivo fluorescence spectrum S:
Sd 	 S
exp	− krmd

4Drmd
, 11
where rmd is the distance from fluorescent markers to detec-
tors.
wavelength (nm)
Reduced Scattering µs’
c
m
-1
700 750 800 850 900 950 1000
6.6
6.8
7
7.2
7.4
7.6
7.8
8
8.2
8.4
(b)
orption and b scattering inspired by Ref. 30.
S
λ
D
λ
µa,
µs’
S(λ)
Sd(λ)
Fig. 3 Schemalic of light propagation after excitation by source s in
breast tissues, and detection of photons emitted back from fluorescent
markers on detectors d.00
a absSeptember/October 2010  Vol. 1555
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JWe can now simulate detected fluorescence signal, depend-
ng on depth r of markers in breast tissues. Decreasing inten-
ity and spectral distortions resulting from the emitted mark-
rs light travel in tissues are shown in Fig. 4 for markers
oved from the surface to 10 cm deep in breast tissues.
.5 Source Number Determinacy
hen running NMF on our spectroscopic data, we assume
hat the number of sources we are looking for is equal to the
umber of the different specific markers injected, plus one for
he autofluorescence contribution. Distortion of fluorescence
pectra could lead to an increase in the number of sources to
nmix; in a case where a same marker is present at different
epths in a medium, fluorescence spectrum emitted by the
eepest markers appear distorted compared to the less deeply
mbedded markers.
When the number of sources to unmix is not empirically
hosen, a method to define it is to compute the SVD of initial
ata M:
M = U
V , 12
here matrix U contains spatial information of fluorescence
ources, matrix V contains spectral information, and 
 gives
he ordered singular values. We thus assume our data can be
xpressed as a separable set of orthonormal spatial and wave-
ength components. By looking at the singular values, we can
efine number of sources in the mixed data by selecting the
rst nonnegligible singular values.
We ran the NMF algorithm on our simulated breast data,
nd give the SVD of data for each depth of markers tested,
rom 0.1 to 10 cm. The results are presented in Fig. 5. While
pectrum distortion should lead us to consider a third source
n our unmixing model, the exponential loss of marker signal
ntensity does actually not allow time for spectra to become
istorted, and SVD only finds two sources.
Since spectrum distortion is insignificant in front of inten-
ity loss of deep embedded markers, looking for an average
pectrum S for a same family of markers, but at different
epths, is sufficient in diffusive optical imaging. In last sec-
ion, an in vivo unmixing example will confirm that result.
(a)
0
10
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Wavelength (nm)
ig. 4 Normalized fluorescence spectra of simulated markers: a spe
urface to 10 cm deep in simulated breast tissues.ournal of Biomedical Optics 056009-
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Many hybrid NMF algorithms, most often dealing with spar-
sity and smoothness constraints, were developed in the last
5 y, most of them trying to directly adapt from Lee and Se-
ung’s multiplicative update rules.31,32 Kim and Park33 became
interested in sparse NMFs by L1-norm constraint term mini-
mization; Cichocki et al.34 presented cost functions no longer
based on the Kullback-Leibler divergence but on Csiszár’s
-divergence; while other approaches use alternative cost
functions formulations.35,36 We propose in this section to
study the effect of initialization of matrices A and S on NMF
solutions, and we present regularized NMF update rules,
adapted to spectral imaging, that deal with the a priori knowl-
edge on the fluorescence spectra considered.
4.1 Influence of Initialization on NMF Decomposition
Choice of initialization is once more fundamental and NMF
decomposition directly depends on the initial guess on matri-
ces A and S. In that part, we study the influence of initializa-
(b)
0
0.5
1
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3
3.5
x 10
4
1 mm
1 mm
intensity
decrease
Wavelength (nm)
istortion and b intensity loss observed for markers moved from the
1 2 3 4 5
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Singular values ordering
S
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Fig. 5 From 1 mm to 10 cm in breast tissues; even if fluorescence
spectra of markers are distorted by traveling tissue, only two fluores-
cence sources markers and autofluorescence are considered in the
unmixing model.ctrum dSeptember/October 2010  Vol. 1556
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Jion on our simulated example. Gaussian spectra similar to
imulation spectra of matrix S are chosen to initialize the
MF algorithm. We observe the influence of wavelength
ranslation of initialization spectra on the NMF decomposi-
ion. For this specific example, initialization spectra for matrix
0 are translated on a range of 100 nm, on both sides of
imulation spectra, as depicted Fig. 6.
To underline the dependence of NMF result to initializa-
ion, three cases are presented. For each case, resulting con-
rast for different depths of fluorescent markers in tissue from
.1 to 4 cm is obtained.
First we observe healthy tissue/tumor contrast on raw data,
ithout any unmixing processing: contrast and detection are
aturally decreasing with depth 	see Fig. 7a
. Then NMF
rocessing is applied on data but with random initialization
random nonnegative values for matrices A and S, 30 draws
er depth: unmixing processing improves detection 	see Fig.
b
. Finally, NMF algorithm with this time Gaussian initial-
zation for S Gaussian models are translated in a 100-nm
700 750 800 850 900 950 1000
0
20
40
60
80
100
Simulated
spectra
Wavelength (nm)
Initializations
ig. 6 Influence of initialization on NMF decomposition is studied on
imulated example: initial spectra of matrix S0 are translated simul-
aneously for this example in a range of 100 nm on both sides of
xpected spectra.
translated gaussian for matrix S
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ig. 7 Influence of initialization on resulting contrast breast simula-
ion example.ournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1range is tested: even with less appropriate initialization in
that case, when both simulation spectra are translated 50 nm
up that simulation models for initialization, contrast is im-
proved compared to both prior cases 	see Fig. 7c
.
NMF processing without any a priori information still im-
proves resulting contrast compared to results on raw data.
Then, Gaussian initialization refines results.
But the initialization guess is not obvious. When the ini-
tialization spectrum is translated 50 nm from the expected
spectra, this initialization leads to better result than if initial-
ization is equal to simulated spectra. One explanation may be
that we move away from the crossing area where fluorescence
spectra overlap and where indeterminacy between autofluo-
rescence and fluorescence of markers is high. Moreover, the
obtained contrast is not symmetric on both sides of the
0-shifted spectra: the fluorescence of markers is spatially re-
straint compared to the autofluorescence background see Fig.
1, and moving away to an initialization zone where the fluo-
rescence marker spectrum does not clash with the autofluo-
rescence spectrum emission is advantageous.
From that example, we show initialization choice is very
sensitive, but necessary to improve marker detection. Even if
an approximate initialization already improves contrast be-
tween tumor area and healthy tissue compared to the algo-
rithm with random initialization see Fig. 7, a more accurate
initialization selection may push back the detection limits.
Such selection can be obtained with a multistart initializa-
tion step prior to the NMF algorithm we proposed earlier.
4.2 New Multiplicative Update Rules
As explained in previous section, a priori knowledge of fluo-
rescence sources enables refining the range of solutions. By
choosing appropriate initialization, detection of marked tu-
mors can be improved. Another way to restrain the solutions
set is to constrain the initial cost function F; we propose in
this section to lightly modify the cost function, and find a new
regularized algorithm to minimize updated cost function.
4.3 A Priori Knowledge on the Fluorescence
Sources
In the optical spectroscopy context, injected markers are
known and could thus ease the unmixing problem. But
whether it refers to the specific markers, or to the autofluores-
cence of biological tissues, we can actually not define a pre-
cise model of the fluorescence spectra. Spectra of the specific
markers may vary from the ex vivo known spectra once in-
jected in vivo and illuminated. In the in vivo medium, the
markers may create new products that are able, in turn, to
emit unknown fluorescence signals. Fluorescence spectra may
also vary with the pH values in the medium, and their inten-
sity may decline with time due to the photobleaching phe-
nomenon. Even if chemical modifications appear on fluores-
cent molecules under illumination or due to the receiver
medium components, we usually observe after that a constant
emission spectrum except in the case of distortion of spectra
due to depth of tissue, explained later. Finally, the optical
parameters of the biological tissues—diffusion and
absorption—cause emissions fluorescence spectra to vary
with the depth of the fluorescent source. This last problem
was treated in simulation and presented in previous section.September/October 2010  Vol. 1557
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Jegarding the autofluorescence of tissues, as for the specific
arkers, the illumination may be responsible for the creation
f new products. Furthermore, autofluorescence spectrum
ay vary according to the pH of analyzed area,37 or according
o the patient.38–40 But once measured, the in vivo autofluo-
escence spectrum usually not differs across the organism be-
ng observed. An example of mouse autofluorescence acqui-
ition is given Fig. 8, where normalized spectra remain
onstant across the mouse body. We assume this property
hould also be true for specific human area observed prostate,
reast, etc..
For slightly different autofluorescence emission spectra,
he average spectrum is sufficient for NMF decomposition a
imilar case is that for distorted fluorescent markers with
epth.
Even if fluorescence spectra may not be initially perfectly
efined, we still have some a priori information concerning
hem, from ex vivo and empirical measurements. The emis-
ion wavelength range, and the shape of the expected spectra
ay be globally known and used to refine solutions set.
.4 NMF Initialization Step
he initialization step uses a priori models to guide the solu-
ions, but lets the algorithm, thanks to its blind specificity, to
dapt solutions depending on the original experimental data.
e would like the algorithm to take into account that piece of
nformation: we thus define a new cost function to minimize,
hat directly depends on S0.
.5 New Cost Function and Regularized Update
Rules
he new cost function F2 is now defined as the sum of the
quare of the Euclidean distance between M and AS plus a
(a)
Autofluorescence intensity
ri
Anesthetized mouse
ri
i (1,70)
A
Fig. 8 Autofluorescence acquisition of noninjected mouse:ournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1regularization term on the initialization S0, weighted by a
regularization vector  of length P:
F2 = 
n=1
Ns

=1
N mn − 
p=1
P
anpsp2 + 
p=1
P
p
=1
N
sp − s0p
2
,
13
or rewritten in matrix form:
F2 = M − AStM − AS + S − S0tDS − S0 , 14
where D=diag	1 ,2 , . . . ,p
 is a diagonal matrix contain-
ing the P regularization parameters associated to the P spectra
of matrix S−S0.
The regularization term lets S vary from S0, according to
the confidence we have in the initialization. Then F2 is mini-
mized by alternatively updating matrices A and S, with re-
spect to A ,S0. We propose to use original multiplicative
regularized update rules, defined as follows.
Theorem 2. The function F2 is nonincreasing under the up-
date rules:
Sp← Sp
AtM + DS0p
AtAS + DSp
Anp← Anp
MStnp
ASStnp
,
15
with D=diag	1 ,2 , . . . ,p
.
The value of  must be set according to the level of con-
fidence in the a priori information on the initial spectra. We
can also use different degree of confidence on the different
spectra by using a vector .
(b)
750 800 850 900 950
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40
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100
Wavelength (nm)
Normalized spectra
autofluorescence spectra
750 800 850 900 950
0
1000
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nsity map and b associate average raw by raw spectra.a inteSeptember/October 2010  Vol. 1558
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JWe prove Theorem 2 in the appendix, by using an auxiliary
unction as in Refs. 11 and 12, and conserving the maximum
f the mathematical notations of Lee and Seung in Ref. 12. To
llustrate the efficiency of NMF on spectroscopic data, we
ropose now an example on in vivo experimental data, where
p to three different fluorescence sources need to be unmixed.
Spectral Unmixing on Experimental Data
or in vivo experiments, an autofluorescence signal is neces-
arily measured. Then several specific markers may be used to
imulate marked targets, such as tumors. In this section, we
est NMF to unmix three overlapping different fluorescence
ources, including the autofluorescence on mice.
To acquire spectrally resolved measurements, the animal
as illuminated with a planar laser at 690 nm. The emitted
ack fluorescence signal was collected along a line of Nx
oints by a spectrometer coupled with a charge-coupled de-
ice camera Andor Technologies: a NxN acquisition was
easured see Fig. 9. For this experiment, Nx was equal to
50 and N to 1024, which corresponds to a wavelength range
round 600 to 975 nm. A translation stage, covering Ny steps,
as then used to get a scanning of the whole animal: Ny
aser source
690 nm
Spectrometer
Translation stage: Nysteps
anesthezia
B&W
camera
Nλ
Nx
80 90 100
50
80 90 100
50
10 20 30 40 50 60 70 80 90 100
50
10
150
20
250
Ny
CCD camera
Nx
ig. 9 Experimental setup for acquisition of the animal and data
rocessing.
Anesthetized mouse
ICG-
LNP
Capillary
tube
(a) (b)
Alexa
750
Small incision
Anatomy
ig. 10 a Schematic of the mouse with two capillary tubes filled wi
esult without any capillary autofluorescence signal only, and d
CG-LNP + Alexa 750.ournal of Biomedical Optics 056009-
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1acquisitions were obtained, each of size NxN. Before to
run the NMF algorithm, mixed data of size NyNxN
were reordered as a 2-D array of size NyNx ,N Ns is
defined in NMF equation is now equal to NyNx. Sepa-
rately, a black and white picture of the animal may be taken,
to superimpose fluorescence signal and environment image if
necessary.
For each in vivo experiment, a precise protocol is defined.
All protocols have in common the following cares. The ani-
mal procedure is in compliance with the guidelines of the
European Union regulation No. 86/609, taken in the French
law decree 87/848 regulating animal experimentation. All
efforts are made to minimize animal suffering. The animal
manipulation is performed with sterile techniques and ap-
proved by the Grenoble Animal Care and Use Committee
France registration number 20_iRTSV Léti-FNG-02. An
adult female nude mouse Janvier, Le Genest saint-isle,
France are used throughout the experiments. They are housed
in approved facilities, at 211 °C under diurnal lighting
conditions. The mice arrive at the animal facility 2 weeks
before the experiments start and had free access to food and
water.
5.1 Multimarker Experiment
5.1.1 Presentation
We present a first feasibility experiment on a mouse. Two
glass capillary tubes respectively filled with 5 l of indocya-
nine green loaded into lipid nanoparticules41 ICG-LNP at
0.35 mol / l and 5 l of Alexa 750 at 0.1 mol / l were in-
serted subcutaneously to simulate marked targets 	see Fig.
10a
. Three distinct fluorescent sources—autofluorescence,
ICG-LNP, and Alexa 750—whose emission spectra are over-
lapping had to be unmixed. To draw a parallel between acqui-
sitions with or without specific fluorescence, a first acquisition
of the animal was run as a reference, without any specific
markers inserted.
In this precise example, we chose =1010 to constraint the
autofluorescence spectrum to remain close to initialization
(c) (d)
Acquisitions
capillary tube
Autofluorescence)
ICG-LNP
Alexa 750
ICG-LNP + Alexa 750 tubes
(Autofluorescence + ICG-LNP
+ Alexa 750)
T1T2
N
C T2 ,N
= 0.3631
C T1 ,N
= 0.2123
LNP and Alexa 750; b anatomy scheme of the mouse, c scanning
ng result with the two capillary tubes inserted autofluorescence +No
(
th ICG-
scanniSeptember/October 2010  Vol. 1559
93.48.255.141. Terms of Use:  http://spiedl.org/terms
a
e
o
s
b
i
m
n
t
i
5
F
w
r
t
r
k
s
t
m
7
r
c
p
A
c
1
1
f
t
m
I
v

c
s
a
p
F

Montcuquet et al.: Nonnegative matrix factorization: blind spectra separation method…
Jnd have a plausible profile, and =0 for ICG-LNP, and Al-
xa 750 spectra. The regularization term helped to smooth
ver aberrations due to the two components crosstalk on re-
ulting spectra. We chose initialization from empirical results,
ut could not use multistart initialization: regularization on
nitialization asks for coherent initialization spectra, while
ultistart initialization may use translated spectra uncon-
ected to real expected fluorescence spectra. The choice has
o be made between different regularization methods, depend-
ng on application.
.1.2 Results
igure 10c shows the reference acquisition of the mouse
ithout any capillary: the autofluorescence is the only fluo-
escence signal measured. Autofluorescent areas may be at-
ributed to some specific organs, known to emit natural fluo-
escence, such as the stomach, the liver, the intestine, or the
idneys of the animal, if we compare the autofluorescence
canning to the anatomy scheme of a mouse 	Fig. 10b
. In
he same figure, we present the resulting scanning of the
ouse with the two capillary tubes of ICG-LNP and Alexa
50 	Fig. 10d
, on which the regularized NMF algorithm is
un.
Figure 11 presents the overlapping spectra that NMF suc-
essfully unmixed. The three normalized spectra of matrix S
resented in Fig. 11a are weighted by coefficients of matrix
	Fig. 11b
. The three resulting contributions of fluores-
ence are presented in Fig. 12: the autofluorescence 	Fig.
2a
, the ICG-LNP 	Fig. 12b
, and the Alexa 750 	Fig.
2c
. Three sources unmixing allowed improving detection
or each marker, Alexa 750 and ICG LNP. Indeed, initial con-
rast values measured on mixed data, cf. Fig. 10 between
arkers area and normal tissue area were equal to 0.2123 for
CG-LNP and 0.3631 for Alexa 750. After unmixing, contrast
alues respectively reached 0.6366 ICG-LNP and 0.6763
Alexa 750 see Figs. 12b and 12c
.
To conclude concerning this feasibility experiment, a last
omparison is made, between the original autofluorescence
canning without any capillary tube inserted to the animal
nd the separated autofluorescence results obtained for both
ast experiments see Fig. 13. First, a consistent intensity
(a)
ig. 11 Results after NMF: a fluorescence spectra obtained matr
continuous lines, and b weight coefficients matrix A.ournal of Biomedical Optics 056009-1
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1level is obtained after the NMF decomposition. Indeed, the
intensity obtained after NMF decomposition for the autofluo-
rescence part 	Fig. 13b
 is close to the intensity observed on
the reference autofluorescence acquisition 	Fig. 13a
. Fi-
nally, the principal autofluorescent area observed on the au-
tofluorescence scanning 	Fig. 13a
 are also present on autof-
luorescence contribution obtained after the NMF
decomposition 	Fig. 13b
.
5.2 Multidepth Experiment
In a second experiment, we proposed to test the NMF algo-
rithm robustness on a precise case of the same fluorescent
marker at two different depths in mouse tissues. In such a
case, the deeper the markers are embedded in tissues, the
more their fluorescence spectra are distorted and their inten-
sity is exponentially decreased.
Two glass capillary tubes both filled with 5 l of ICG-
LNP Ref. 41 at 5 mol / l were inserted to simulate marked
targets. The first tube was inserted subcutaneously around
1 mm deep, while the second one was placed in the rectum
of the animal around 6 mm deep from the surface, as de-
picted in Fig. 14a. The same experimental setup was used to
scan the mouse see Fig. 9, and the obtained data are pre-
sented Fig. 14b. The 6-mm-deep marker signal was mixed
with the autofluorescence signal and masked by the
1-mm-deep intense marker signal, and the
5 mm-deep-difference was responsible for light distortion
emission peak translation and loss of intensity between both
emitted spectra, measured in the rectum or subcutaneously
	see Fig. 14b
.
5.2.1 Results
As for the previous experiment, we ran the NMF algorithm on
the mixed data to obtain separated fluorescence contributions
of autofluorescence and the specific ICG-LNP fluorescence.
The results are presented Fig. 15, with a unique average spec-
trum obtained in matrix S after NMF decomposition for the
ICG-LNP despite the slightly different spectra emitted from
the subcutaneous and rectum capillaries see Fig. 15, ICG-
LNP dotted line, and accurate unmixing results were ob-
(b)
initialization dotted lines, and results of the NMF decompositionix S:September/October 2010  Vol. 1550
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Jained 	see Figs. 15a and 15b
. Deep markers that were
riginally mixed with autofluorescence signal are now easily
etectable. Indeed, after autofluorescence removal, detection
f 6-mm-deep markers was considerably improved. The ini-
ial contrast value between the ICG-LNP rectum area and the
ormal tissue area was equal to 0.36 before unmixing 	see
ig. 14b
, and reached 0.77 once the fluorescence contribu-
ions were separated 	see Fig. 15b
. Moreover, in the ob-
ained ICG-LNP contribution, all the autofluorescence critical
ones the stomach or intestine, for example were quenched.
Conclusions
e presented a blind positive source separation method ap-
lied to in vivo spectrally resolved data. Beyond the specific
uorescence signal of specific markers used in optical imag-
ng, the autofluorescence of biological tissues was also de-
ected in the wavelength range we used, and must be removed
o achieve accurate detection results. This property increased
ith the depth of biological tissues explored, since the spe-
ific signal decreases exponentially while the autofluores-
ence signal remains constant. To remove autofluorescence
nd unmix different fluorescent markers whose fluorescence
(a) (b) (c)
ICG-LNPAutofluorescence Alexa 750
CT,N = 0.6763
T
N N
T
CT,N = 0.6366
ig. 12 Results after NMF: a autofluorescence intensity contribution,
b ICG-LNP intensity contribution, and c Alexa 750 intensity
ontribution.
Original autofluorescence
measurement
Autofluorescence
after NMF
(a) (b)
ig. 13 a Autofluorescence measurement, without any specific fluo-
escence no capillary tubes added and b autofluorescence contri-
ution obtained after NMF decomposition two capillary tubes of
CG-LNP and Alexa 750 experiment.ournal of Biomedical Optics 056009-1
Downloaded from SPIE Digital Library on 04 Apr 2011 to 1spectra are not perfectly known, a blind source separation
method, the NMF, was chosen. By notably taking into account
the nonnegativity of the data, it is particularly suitable for
fluorescence imaging data. We briefly presented this classical
method, from the choice of the cost function and the optimi-
zation step that minimizes it and leads to a nonunique NMF
decomposition. Indeed, when using blind source separation,
we estimated fluorescence sources without knowing the mix-
ing process; without some a priori knowledge, it is not pos-
sible to uniquely estimate the sources. We presented studies of
simulated breast data that underline interest of a priori infor-
mation for initialization choice and additional constraints that
may be applied to cost functions. An original regularized
NMF algorithm that takes into account some prior knowledge
about the fluorescence spectra was proposed. We did not dis-
cuss a method to chose the value of the regularization param-
eter, which is currently empirically chosen. Finally, our theory
was successfully validated with in vivo experiments on mice.
The aim of those experiments was to remove the autofluores-
cence contribution from the experimental data, and to unmix
upto two specific markers, or the same fluorescent marker at
different depths in tissues. NMF computed satisfactory results
and enabled us to localize specific marker contributions ini-
tially lost in the autofluorescence signal.
As optical imaging tries to detect deeper and deeper em-
bedded targets, NMF is a useful preprocessing step to remove
unwanted autofluorescence and unmix different spectra of in-
terest. By returning separated fluorescence contribution data,
the method presents the possibility to perform accurate to-
mographic reconstructions and thus to confirm the 3-D posi-
tion of marked tumors.
Appendix: Theorem 1: Proofs of Convergence
In this section, we propose a proof of convergence of Theo-
rem 2. Note that a proof for convergence of the update rule for
A was already given by Lee and Seung.12 We introduce the
following definition:
Anesthezia (isofluorane)
Rectum capillary
(6 mm deep)
Subcutaneous
capillary
(1 mm deep)
Mixed data
AcquisitionExperiment
Supine position
(a) (b)
750 800 850 900 950
Wavelength (nm)
subcutaneous
rectum
TN
C T,N = 0.36
Fig. 14 a Two capillary tubes of ICG-LNP are placed at two different
depths and b intensity data obtained and average fluorescence spec-
tra measured in the capillary tubes.September/October 2010  Vol. 1551
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Jefinition 1. Gs ,si is an auxiliary function for F2s if the
ollowing conditions are satisfied:
Gs,si F2s and Gs,s = F2s . 16
he auxiliary function definition is useful for the following
emma:12
emma 1. If G is an auxiliary function for F2, then F2 is
onincreasing under the update:
si+1 = argmins Gs,si 17
emma 1 is illustrated in Fig. 16.
By defining an appropriate auxiliary function G for F2, as
efined earlier, the update rules presented in Theorem 1 sim-
ly follow from Lemma 1 	Eq. 17
. The auxiliary function
is presented in the following lemma.
emma 2. If Ksi is the diagonal matrix
Fluorescent
markersAutofluorescence
Weights
intestine
capillary
tubes
(a) (b)
TN
C T,N = 0.77
ig. 15 Unmixing results: a and b weights matrix A of respectiv
matrix S obtained at convergence, and a comparison with unmixed s
ectum.
ss
min
si+1si
G(s,si)
F2(s)
si +2
ig. 16 Minimizing the auxiliary function Gs ,siF2s ensures that
si+1F si for si+1=argmin Gs ,si.2 2 s
ournal of Biomedical Optics 056009-1
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abAtAsi +  sia
sa
i , 18
then, setting s= s−si,
Gs,si = F2si + st  F2si +
1
2
stKsis , 19
is an auxiliary function for
F2s =
1
2i vi − a Aiasa
2
+

2a sa − s0a
2
. 20
Proof of lemma 2. Gs ,si is an auxiliary function for F2s
if the conditions defined in Eq. 16 are verified. If Gs ,s
=F2s is obvious, the second condition Gs ,siF2s must
be demonstrated.
Let F2 be the gradient of F2 and HessF2 the Hessian
matrix. We obtain
F2s = F2si + st  F2si +
1
2
stHessF2s , 21
with
F2si =
1
2
m − Asi2 +

2
si − s0
i 2 =
1
2
m − Asitm − Asi
+

2
si − s0
i tsi − s0
i  , 22
and finally the gradient is
F2si = AtAsi − m + si − s0i  , 23
while the Hessian matrix gives
Subcutaneous
capillary spectrum
Rectum capillary
spectrum
FMN solution
Spectra
(c)
Wavelength (nm)
750 800 850 900 9500
0
0
0
0
0
ICG-LNP
autofluorescence
tofluorescence and ICG-LNP fluorescence, and c unmixed spectra
measured in capillary tubes on the mouse, subcutaneously and in the2
4
6
8
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ely au
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JHessF2 = AtA + aIp, 24
here I is the pp identity matrix.
Thus,
Gs,si − F2s = F2si + st  F2si +
1
2
stKsis − F2si
− st  F2si −
1
2
stHessF2s
=
1
2
st	Ksi − HessF2
s =
1
2
stKsi
− AtA − Is . 25
Hence, the following equivalence is given
Gs,si F2s ⇔ st	Ksi − AtA − I
s 0. 26
We can now demonstrate that st	Ksi−AtA−I
s is
ositive:
st	Ksi − AtA − I
s
= 
ab
sa	Ks − AtA − I
absb
= 
ab
saabAtAsi + sia
sa
i sb − 
ab
sa	AtA
+ Iab
sb
= 
ab
sa abc d AdaAdcsci  + sai 
sa
i
sb
− 
ab
sa
d
AdaAdb − absb
= 
a,c,d
AdaAdcsasa sci
sa
i − sasc
+ 
a
sa  sai
sa
i − sa = 12 a,c,d AdaAdcsa scsa
1/2
− sc sa
sc
1/22 0. 27
ollowing is a demonstration of Theorem 1.
roof of theorem 1. Lemma 1 gives si+1=argminsGs ,si.
Since
∀a,
Gs,si
sa
i = 	F2s
a + 	Kss
a = 0 ⇒ s =
− Ks−1  F2s , 28
e obtainournal of Biomedical Optics 056009-1
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b
Kabsi−1 	AtAsi − m + si − s0i 
b.
29
Thus,
sa
i+1
= sa
i Atv + s0
i a
AtAsi + sia
. 30
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